EORTC-55994 and Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
EORTC and the trial from TATA memorial. Is neoadjuvant chemotherapy and surgery an alternative to chemoradiation in locally advanced cervical cancer?
Study Summaries
DUO-E Trial
Does adding durvalumab (a PD-L1 inhibitor) and olaparib (a PARP inhibitor) to standard chemotherapy improve outcomes in advanced or recurrent endometrial cancer?
OUTBACK Trial: Chemotherapy after Chemoradiation
OUTBACK trial